Escalating de-escalation in breast cancer treatment

Intelligent Vacuum-Assisted Biopsy to Identify Breast Cancer Patients With Pathologic Complete Response (ypT0 and ypN0) After Neoadjuvant Systemic Treatment for Omission of Breast and Axillary Surgery

(2022) André Pfob et al.   JOURNAL OF CLINICAL ONCOLOGY

Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer–Related Lymphedema

(2022) Giacomo Montagna et al.   JAMA Oncology

Predicting of Sentinel Lymph Node Status in Breast Cancer Patients with Clinically Negative Nodes: A Validation Study

(2021) Annarita Fanizzi et al.   Cancers

Adjuvant T-DM1 versus Trastuzumab in Patients with Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer: Subgroup Analyses from KATHERINE

(2021) E.P. Mamounas et al.   ANNALS OF ONCOLOGY

Combined breast conservation therapy versus mastectomy for BRCA mutation carriers – A systematic review and meta-analysis

(2021) M.G. Davey et al.   BREAST

Breast MRI for Evaluation of Response to Neoadjuvant Therapy

(2021) Beatriu Reig et al.   RADIOGRAPHICS

A National Survey of Breast Surgeons and Radiation Oncologists on Contemporary Axillary Management in Mastectomy Patients

(2021) Chandler S. Cortina et al.   ANNALS OF SURGICAL ONCOLOGY

Optimizing Axillary Management in Clinical T1-2N0 Mastectomy Patients with Positive Sentinel Lymph Nodes

(2021) Olga Kantor et al.   ANNALS OF SURGICAL ONCOLOGY

Evaluation of risk stratification using gene expression assays in patients with breast cancer receiving neoadjuvant chemotherapy

(2021) Sung Jun Ma et al.   BREAST CANCER RESEARCH AND TREATMENT

Does preoperative MRI accurately stratify early-stage HER2 + breast cancer patients to upfront surgery vs neoadjuvant chemotherapy?

(2021) Astrid Botty van den Bruele et al.   BREAST CANCER RESEARCH AND TREATMENT

Risk-based decision-making in the treatment of HER2-positive early breast cancer: Recommendations based on the current state of knowledge

(2021) Christian Jackisch et al.   CANCER TREATMENT REVIEWS

Preoperative breast magnetic resonance imaging in patients with ductal carcinoma in situ: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC)

(2021) Carlos Canelo-Aybar et al.   EUROPEAN RADIOLOGY

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer

(2021) Andrew N.J. Tutt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Three-Year Follow-up of Neoadjuvant Chemotherapy With or Without Anthracyclines in the Presence of Dual ERBB2 Blockade in Patients With ERBB2-Positive Breast Cancer

(2021) Anna van der Voort et al.   JAMA Oncology

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study

(2021) N. Harbeck et al.   ANNALS OF ONCOLOGY

Adjuvant trastuzumab with or without chemotherapy in stage 1 pT1N0 HER2+ breast cancer: a National Cancer Database analysis

(2021) Lifen Cao et al.   BREAST CANCER RESEARCH AND TREATMENT

Axillary ultrasound and fine-needle aspiration cytology to predict clinically relevant nodal burden in breast cancer patients

(2021) Isabela Panzeri Carlotti Buzatto et al.   World Journal of Surgical Oncology

Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomy

(2020) Audree B. Tadros et al.   BREAST CANCER RESEARCH AND TREATMENT

Pembrolizumab for Early Triple-Negative Breast Cancer

(2020) Peter Schmid et al.   NEW ENGLAND JOURNAL OF MEDICINE

The 21-gene recurrence score in node-positive, hormone receptor-positive, HER2-negative breast cancer: a cautionary tale from an NCDB analysis

(2020) Roi Weiser et al.   BREAST CANCER RESEARCH AND TREATMENT

Comparison of BSGI, MRI, mammography, and ultrasound for the diagnosis of breast lesions and their correlations with specific molecular subtypes in Chinese women

(2020) Hongbiao Liu et al.   BMC MEDICAL IMAGING

St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment

(2019) Marija Balic et al.   Breast Care

Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

(2019) Sara M. Tolaney et al.   JOURNAL OF CLINICAL ONCOLOGY

Anthracyclines in Early Breast Cancer: The ABC Trials—USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)

(2017) Joanne L. Blum et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy

(2017) Norikazu Masuda et al.   NEW ENGLAND JOURNAL OF MEDICINE

How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study

(2016) Anita Mamtani et al.   ANNALS OF SURGICAL ONCOLOGY

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

(2013) Thorsten Kuehn et al.   LANCET ONCOLOGY

US Appearance of Ductal Carcinoma in Situ

(2013) Lilian C. Wang et al.   RADIOGRAPHICS

Nomogram for Predicting the Risk of Local Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In Situ

(2010) Udo Rudloff et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III Trial Evaluating the Addition of Paclitaxel to Doxorubicin Followed by Cyclophosphamide, Methotrexate, and Fluorouracil, As Adjuvant or Primary Systemic Therapy: European Cooperative Trial in Operable Breast Cancer

(2009) Luca Gianni et al.   JOURNAL OF CLINICAL ONCOLOGY

Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast Cancer

(2008) Wendie A. Berg   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Relationship of Breast Magnetic Resonance Imaging to Outcome After Breast-Conservation Treatment With Radiation for Women With Early-Stage Invasive Breast Carcinoma or Ductal Carcinoma in Situ

(2008) Lawrence J. Solin et al.   JOURNAL OF CLINICAL ONCOLOGY